Back to search

Article

Enhanced splicing modulation by NMA-modified antisense oligonucleotides

2025-10-07

Abstract excerpt

Aberrant RNA splicing contributes to many human diseases, and splice‑switching antisense oligonucleotides (SSOs) are ideally suited as a therapeutic strategy to modulate splicing and restore normal gene expression. Nusinersen (Spinraza™) has revolutionized the treatment of spinal muscular atrophy. It is a splice-switching oligonucleotide (SSO) that is modified with 2′- O -methoxyethyl (MOE) modifications. Here, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0bba2a8f-c0e9-596b-8776-6d480664fe8f
DOI
10.1101/2025.10.06.680653
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced splicing modulation by NMA-modified antisense oligonucleotidesDOI 10.1101/2025.10.06.680653
Select a neighboring publication to make it the new centre.